Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company that completed its business combination with Mountain Crest Acquisition Corp. II, sponsored by Mountain Crest Capital LLC, in 2021. Operating in the healthcare technology sector, the company focused on developing software-based therapeutics targeting cardiometabolic diseases. The March 2024 8-K filing, submitted under accession number 0001193125-24-068672, reflects a period of significant corporate transition following the company's disclosure of operational and financial challenges. BTTX's trajectory illustrates the post-merger pressures facing de-SPAC companies in the digital health space. For full filing history, deal terms, and status tracking on Better Therapeutics and thousands of other SPAC transactions, sign up for complete data access at SpacDesk.